HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

amonafide

DNA topoisomerase II inhibitor;structure given in first source
Also Known As:
5-amino-2-(2-dimethylaminoethyl)benzo(de)isoquinolin-1,3-dione; FA 142; M-FA 142; M-FA-142; MFA 142; MFA-142; NSC 308847; NSC-308847; benzisoquinolinedione; nafidimide; 1H-Benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl)-
Networked: 74 relevant articles (9 outcomes, 39 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Qian, Xuhong: 6 articles (06/2013 - 03/2010)
2. Xu, Yufang: 6 articles (06/2013 - 03/2010)
3. Liu, Jianwen: 6 articles (06/2013 - 03/2010)
4. Allen, Steven L: 3 articles (04/2015 - 04/2010)
5. Lundberg, Ante S: 3 articles (04/2015 - 04/2010)
6. Shen, Ke: 3 articles (06/2013 - 10/2012)
7. Li, Qi: 3 articles (06/2013 - 02/2013)
8. Liang, Xin: 3 articles (04/2013 - 03/2010)
9. Zhao, Jin: 3 articles (10/2012 - 07/2009)
10. Zhang, Huanying: 2 articles (06/2013 - 03/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Leukemia
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Adenocarcinoma
5. Leukopenia

Related Drugs and Biologics

1. trioctyl phosphine oxide (TOPO)
2. Cytarabine (Cytosar-U)
3. DNA (Deoxyribonucleic Acid)
4. Daunorubicin (Cerubidine)
5. malic acid (malate)
6. Trimetrexate (JB11)
7. Etoposide (VP 16)
8. Doxorubicin (Adriamycin)
9. Idarubicin (4 Demethoxydaunorubicin)
10. Mitoxantrone (Novantrone)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Transplants (Transplant)
3. Remission Induction
4. Heterologous Transplantation (Xenotransplantation)
5. Radiotherapy